Find your path to Ray
202 people in our graph share verified history with Ray — schools, employers, funds. One of them is your warm intro.
Erin MooreunlockedRay: together at GSK (2005–2009)
×7Ray: together at GSK
×4Ray: together at Andersen Consulting
About
Ray Stevens is a biotechnology executive who advises CEOs, boards, and venture investors as a strategic advisor and fractional COO and CEO through High Pass Partners. His career spans large pharmaceutical companies, including GSK, and venture-backed biotechnology companies, with involvement from discovery through late-stage development and regulatory readiness. As a founder and executive, he has built and led drug development programs across areas including CMC, clinical development, regulatory strategy, operations, and capital allocation.
Chief Executive Officer at Renbioscience
Intro paths
→
In turn, Ray can intro founders to Renbioscience's investors below.
Renbioscience's investors · 1
Experience
- High Pass PartnersBiotech Executive Advisor | Fractional CEO & COOcurrent2024 — presentPhiladelphia, PA
- Ren BioScienceChief Executive Officercurrent2020 — presentWest Chester, PA
- Nalo TherapeuticsHead of CMC2022 — 2025
- B3AR TherapeuticsChief Executive Officer2021 — 2025Palo Alto, CA
- Velicept Therapeutics / AltheRx Pharmaceuticals / B3AR TherapeuticsFounder / Chief Operating Officer2010 — 2021Malvern, PA
- GSKVice President; Preclincal IT2008 — 2009Upper Merion, PA
- GSKDirector Preclinical IT2006 — 2008Upper Merion, PA
- GSKDirector GSK Ventures Deal Team Lead2004 — 2006Upper Merion, PA
- GSKR&D Finance Systems and Integration Leader2000 — 2004
- GSKR&D Capital Planning and Prioritization Leader1998 — 2000
- Andersen ConsultingStrategy Consultant - Product Launch1997 — 1998
Skills & more
Process Improvement6Biopharmaceuticals15Commercialization8Pharmaceutical Industry47Business Planning6Drug Discovery4R&D6Product Development6Lifesciences15Clinical Development21Leadership17Strategy35
+12 more
Cross-functional Team LeadershipClinical TrialsSix SigmaBusiness Process ImprovementBusiness StrategyManagementOncologyNegotiationStrategic PlanningManufacturingIT StrategyBiotechnologyFrom Ray's professional profile.
Frequently asked questions
- Who is Ray Stevens?
- Ray Stevens is a biotechnology executive who advises CEOs, boards, and venture investors as a strategic advisor and fractional COO and CEO through High Pass Partners. His career spans large pharmaceutical companies, including GSK, and venture-backed biotechnology companies, with involvement from discovery through late-stage development and regulatory readiness. As a founder and executive, he has built and led drug development programs across areas including CMC, clinical development, regulatory strategy, operations, and capital allocation.
- Where does Ray Stevens work?
- Ray Stevens is Chief Executive Officer at Renbioscience.
- Where did Ray Stevens go to school?
- Ray Stevens studied at Penn State University (MBA); Penn State University (BSME).
Same school
Also attended Penn State University523
Kelly DonovanExecutive Assistant & Operations Associate, Revolution Growth at RevolutionFallon GoodeExecutive Assistant at March Capital PartnersCristina HohlmanPartner, Chief Financial Officer at Sapphire VenturesNick DolikInvestor at 8VCRobert SoffelRevOps Expert at Notion CapitalLouis BernemanFounding Partner at Osage University Partners
+ 517 more
Shared employers
Also worked at Ren BioScience1
Also worked at GSK279
Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Victoria TaylorInvestor at MedicxiErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesJane SuhPrincipal on the AlleyCorp Healthcare teamCarol SuhPartner at ARCH Venture Partners
+ 273 more
Also worked at Andersen Consulting1,335
Mark SusterManaging Partner at Upfront VenturesChris BrittCo-founder & CEO of ChimeViviana FagaGeneral Partner at Felicis VenturesJulie YangVice President at InvestcorpAmira OujiVice President of Platform & Portfolio Success, Rise of the Rest at RevolutionAntonio GrifoniAssociate at P101 Ventures
+ 1,329 more